We came across a bullish thesis on Harrow, Inc. (HROW) on Simon’s Substack by Simon. In this article, we will summarize the bulls’ thesis on HROW. HROW Technologies, Inc.’s share was trading at $44.07 as of Sept 27th. HROW’s trailing P/E was 9.64 according to Yahoo Finance.
A pharmacist discussing with a patient wearing a face mask, examining their eye to diagnose a macular degeneration.
Harrow (NASDAQ: HROW) is a U.S. pharmaceutical company that develops, produces and sells...
